CAR-T?

Youqin Feng1,2,3,4, Longyuan Wu1,2,3,4, Tianning Gu1,2,3,4

  • 1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

概括

化学抗原受体T (CAR-T) 细胞疗法在治疗血液癌症方面表现有前途. 改善患者选择是最大限度地利用这一突破性治疗方法的关键.